HansHHerfarthMD
Gastroenterology • Chapel Hill, NCProfessor, Medicine, University of North Carolina-Chapel Hill School of Medicine
Dr. Herfarth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 Mason Farm Rd
4151 Bioinformatics
Chapel Hill, NC 27599Phone+1 984-974-0140Fax+1 984-974-0395
Summary
- Dr. Hans Herfarth is a gastroenterologist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. He received his medical degree from Freie University Berlin Faculty of Medicine and has been in practice 26 years. He is experienced in general gastroenterology and inflammatory bowel disease.
Education & Training
Freie University Berlin Faculty of MedicineClass of 1992
Certifications & Licensure
NC State Medical License 2006 - 2026
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (AGAF) American Gastroenterological Association, 2010
Clinical Trials
- Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease Start of enrollment: 2008 May 01
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
- Trial of High Dose Vitamin D in Patient's With Crohn's Disease Start of enrollment: 2015 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsOral vs Intravenous Discharge Antibiotic Regimens in the Management of Intra-abdominal Abscesses in Penetrating Crohn's Disease.Kush Fansiwala, Alison Rusher, Brandon Shore, Hans H Herfarth, Edward Barnes
Inflammatory Bowel Diseases. 2024-12-05 - Efficacy and Safety of Anthocyanin-Rich Extract in Patients with Ulcerative Colitis: A Randomized Controlled Trial.Luc Biedermann, Michael Doulberis, Philipp Schreiner, Ole Haagen Nielsen, Frans Olivier The
Nutrients. 2024-12-04 - Alpha Guy? No, Alpha Gal-Important to Remember in Patients with IBD in Endemic Areas.Alicia Muratore, Edward L Barnes, Millie D Long, Hans H Herfarth, Sarah McGill
Digestive Diseases and Sciences. 2024-11-26
Journal Articles
- Is There a Role for Thiopurines in IBD?Raymond K Cross, Hans Herfarth, Nature
- IBD LIVE Case Series: Case 9: Do Race and Extraintestinal Manifestations Affect Treatment of Severe Crohn’s Colitis?David J Keljo, Joel R Rosh, Samir A Shah, Myron H Brand, Alka Goyal, Brian K Theisen, Hans H Herfarth, Walter A Koltun, Kim L Isaacs, Julia B Greer, Corey A Siegel, Ra..., Inflammatory Bowel Diseases
Press Mentions
ExeGi Pharma Positive Topline Results in EXE-346 PROF Phase 1b StudyDecember 17th, 2024- Proactive Therapeutic Drug Monitoring for BiologicsJune 1st, 2022
5 Questions About Dermatologic and Rheumatologic Manifestations in IBDAugust 30th, 2019- Join now to see all
Grant Support
- Methotrexate Response In Treatment Of UC - Merit-UcNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Methotrexate Response In Treatment Of UCNational Institute Of Diabetes And Digestive And Kidney Diseases2009
- Clinical Trial: Ciprofloxacin For Prophylactic Prevention Of Postoperative EndosNational Center For Research Resources2008
- Pilot Study On The Safety And Efficacy Of Ciprofloxacin For Prophylactic PreventiNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
